Other – Targovax

February 1, 2022

Press release - Non-regulatory

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

IR contact

Dr Lubor Gaal

Chief Financial Officer

lubor.gaal@targovax.com

(+34) 683 343 811

Renate Birkeli

Investor Relations

renate.birkeli@targovax.com

+47 922 61 624

Q2 Second Quarter 2022

Targovax ASA (OSE: TRVX) announced its second quarter and first half 2022 results on Thursday 18 August 2022.

Read the report

This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

Yes, I accept